Topic controls give users more say in what they see, pushing brands to create content tied to clear audience interests. Instagram expanded its Your Algorithm controls to the main feed. This update ...

June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's type 1 diabetes injection in children aged 8 to 17 years who were recently ...

China expanded its trade secret rules to include data and algorithms, as Beijing steps up efforts to prevent technology leaks amid intensifying strategic competition with the US. Effective Monday, the ...

In times past, when we wanted to know which team would win the World Cup, we had to turn to seers with crystal balls, use divination via tea leaves, or hope for Paul the Octopus to tell us what would ...

But unlike most quants, I run a concentrated, fundamentals-based portfolio. More than 50% of my fund is invested in only eight companies, and they're the kinds of stocks that Peter Lynch and Charlie ...

A privacy lawyer says the new Google search feature has risks for users. Here’s what you need to know.

June 12 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's (SASY.PA), opens new tab type 1 diabetes injection in children aged 8 to ‌17 years ...

In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A Chinese-speaking cybercrime group has expanded its targeting to the European space, deploying previously undocumented malware and the Atlas backdoor. Tracked as TA4922, the threat actor is ...

Johnson & Johnson (JNJ) reported new clinical trial results showing that its experimental subcutaneous formulation of amivantamab produced durable responses in patients with advanced head and neck ...